The global stem cell culture media market is estimated to grow at a high rate from 2014 to 2019. Driving factors propelling the growth of stem cell culture media market includes increasing research funding to develop new stem cell lines, growing awareness related to the role of regenerative medicine in disease treatment, and development of advanced genetic methods for stem cell analysis, among others. However, ethical issues related to use of embryonic stem cell lines and technical limitations related to preservation and processing of stem cell lines are some of the key factors hampering the growth of this market.
Emerging markets including China, India, and Brazil have become attractive destinations for companies engaged in the development and distribution of stem cell culture media products. A number of factors such as low regulatory barriers for conducting stem cell-based studies and business friendly environment in developing countries are offering high growth opportunities for players active in the global stem cell culture media market.
BD Biosciences (U.S.), GE Healthcare (U.K.), InVitria (U.S.), Merck KGaA (Germany), Miltenyi Biotech (Germany), Sigma Aldrich Co. LLC (U.S.), Stemgent (U.S.), StemCell Technologies Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), and Vitro Diagnostics Inc. (U.S.) are some of the key players present in global stem cell culture media market. Over the past three years, these companies adopted new product development and launches, collaborations, agreements, partnerships, and geographical expansions as their key business strategies to ensure their growth in this market.
Scope of the Report
This report categorizes the Stem Cell Culture Media Market into the following segments and sub-segments:
Stem Cell Culture Media Market, by Cell Line
Stem Cell Culture Media Market, by Region